Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Puberty | 9 | 2024 | 58 | 3.890 |
Why?
|
| Barrett Esophagus | 13 | 2013 | 107 | 2.310 |
Why?
|
| Esophageal Neoplasms | 14 | 2013 | 110 | 2.010 |
Why?
|
| Obesity | 11 | 2022 | 811 | 1.630 |
Why?
|
| Mindfulness | 3 | 2025 | 30 | 1.570 |
Why?
|
| Adenocarcinoma | 12 | 2013 | 160 | 1.570 |
Why?
|
| Body Mass Index | 14 | 2022 | 925 | 1.370 |
Why?
|
| Gastroesophageal Reflux | 11 | 2014 | 73 | 1.350 |
Why?
|
| Puberty, Precocious | 2 | 2022 | 8 | 1.350 |
Why?
|
| Pediatric Obesity | 2 | 2022 | 101 | 1.290 |
Why?
|
| Female | 41 | 2025 | 12193 | 1.130 |
Why?
|
| Stomach Neoplasms | 6 | 2008 | 39 | 1.120 |
Why?
|
| Diabetes, Gestational | 4 | 2017 | 330 | 1.090 |
Why?
|
| Humans | 48 | 2025 | 16832 | 1.070 |
Why?
|
| Diet | 5 | 2013 | 349 | 1.040 |
Why?
|
| Cardia | 6 | 2008 | 15 | 0.990 |
Why?
|
| Depression, Postpartum | 1 | 2025 | 27 | 0.880 |
Why?
|
| Child | 10 | 2024 | 2433 | 0.860 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2014 | 22 | 0.840 |
Why?
|
| Hepatitis B Vaccines | 2 | 2014 | 44 | 0.830 |
Why?
|
| Hepatitis B | 2 | 2014 | 43 | 0.820 |
Why?
|
| Menarche | 2 | 2022 | 26 | 0.820 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2016 | 206 | 0.740 |
Why?
|
| Pregnancy | 9 | 2025 | 1555 | 0.730 |
Why?
|
| Male | 30 | 2024 | 9556 | 0.730 |
Why?
|
| Adolescent | 15 | 2024 | 3464 | 0.700 |
Why?
|
| Risk Factors | 18 | 2019 | 3108 | 0.680 |
Why?
|
| California | 14 | 2025 | 2244 | 0.680 |
Why?
|
| Adult | 26 | 2025 | 7255 | 0.670 |
Why?
|
| Caregivers | 2 | 2019 | 132 | 0.640 |
Why?
|
| Stress, Psychological | 3 | 2019 | 136 | 0.620 |
Why?
|
| Case-Control Studies | 13 | 2014 | 995 | 0.550 |
Why?
|
| Breast Feeding | 1 | 2019 | 112 | 0.540 |
Why?
|
| Middle Aged | 23 | 2019 | 7515 | 0.530 |
Why?
|
| Antioxidants | 2 | 2008 | 39 | 0.530 |
Why?
|
| Dietary Fiber | 3 | 2013 | 60 | 0.460 |
Why?
|
| Precancerous Conditions | 5 | 2013 | 45 | 0.460 |
Why?
|
| Weight Gain | 1 | 2017 | 167 | 0.450 |
Why?
|
| Young Adult | 11 | 2025 | 2456 | 0.430 |
Why?
|
| Heartburn | 1 | 2014 | 4 | 0.430 |
Why?
|
| Neoplasms | 1 | 2019 | 447 | 0.400 |
Why?
|
| Child, Preschool | 3 | 2024 | 1430 | 0.400 |
Why?
|
| Adiposity | 1 | 2014 | 69 | 0.400 |
Why?
|
| Quality of Life | 3 | 2019 | 477 | 0.400 |
Why?
|
| Surveys and Questionnaires | 7 | 2019 | 1204 | 0.390 |
Why?
|
| Feeding Behavior | 1 | 2014 | 161 | 0.390 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2008 | 55 | 0.390 |
Why?
|
| Infant, Newborn | 3 | 2022 | 828 | 0.390 |
Why?
|
| Prospective Studies | 3 | 2022 | 1186 | 0.390 |
Why?
|
| Alcohol Drinking | 3 | 2014 | 298 | 0.380 |
Why?
|
| Waist Circumference | 1 | 2013 | 34 | 0.380 |
Why?
|
| Patient Compliance | 1 | 2014 | 262 | 0.370 |
Why?
|
| Fruit | 2 | 2010 | 79 | 0.350 |
Why?
|
| Vegetables | 2 | 2010 | 88 | 0.350 |
Why?
|
| Life Style | 3 | 2016 | 305 | 0.340 |
Why?
|
| Aged | 17 | 2018 | 5901 | 0.330 |
Why?
|
| Cohort Studies | 4 | 2022 | 2396 | 0.330 |
Why?
|
| Smoking | 2 | 2014 | 373 | 0.330 |
Why?
|
| Yoga | 1 | 2011 | 25 | 0.330 |
Why?
|
| Micronutrients | 1 | 2010 | 9 | 0.320 |
Why?
|
| Telemedicine | 2 | 2025 | 190 | 0.290 |
Why?
|
| Meat | 1 | 2009 | 27 | 0.290 |
Why?
|
| Beer | 1 | 2008 | 9 | 0.290 |
Why?
|
| Wine | 1 | 2008 | 17 | 0.280 |
Why?
|
| Dietary Fats | 1 | 2009 | 88 | 0.280 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 653 | 0.260 |
Why?
|
| Age Factors | 4 | 2019 | 814 | 0.260 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 1233 | 0.260 |
Why?
|
| Continental Population Groups | 3 | 2019 | 255 | 0.250 |
Why?
|
| Feasibility Studies | 3 | 2019 | 108 | 0.250 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2025 | 515 | 0.240 |
Why?
|
| Transients and Migrants | 1 | 2005 | 3 | 0.230 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2025 | 5 | 0.230 |
Why?
|
| Mexican Americans | 1 | 2005 | 43 | 0.220 |
Why?
|
| Heart Failure | 1 | 2011 | 403 | 0.220 |
Why?
|
| Risk-Taking | 1 | 2005 | 92 | 0.220 |
Why?
|
| Incidence | 7 | 2010 | 1229 | 0.210 |
Why?
|
| Sexual Maturation | 1 | 2024 | 7 | 0.210 |
Why?
|
| Hawaii | 1 | 2024 | 62 | 0.210 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 657 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 317 | 0.200 |
Why?
|
| Coffee | 1 | 2003 | 5 | 0.190 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 202 | 0.190 |
Why?
|
| Treatment Outcome | 2 | 2019 | 1098 | 0.180 |
Why?
|
| Logistic Models | 4 | 2008 | 796 | 0.170 |
Why?
|
| Overweight | 2 | 2014 | 262 | 0.170 |
Why?
|
| Depression | 1 | 2025 | 479 | 0.170 |
Why?
|
| Sex Factors | 4 | 2013 | 560 | 0.150 |
Why?
|
| SEER Program | 3 | 2004 | 86 | 0.150 |
Why?
|
| Mental Health | 1 | 2021 | 161 | 0.150 |
Why?
|
| Retrospective Studies | 2 | 2024 | 2463 | 0.150 |
Why?
|
| Hispanic Americans | 4 | 2021 | 350 | 0.150 |
Why?
|
| HIV Infections | 1 | 2005 | 708 | 0.150 |
Why?
|
| Meditation | 1 | 2019 | 17 | 0.140 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 76 | 0.140 |
Why?
|
| Helicobacter Infections | 2 | 2008 | 19 | 0.140 |
Why?
|
| Helicobacter pylori | 2 | 2008 | 21 | 0.140 |
Why?
|
| European Continental Ancestry Group | 5 | 2021 | 400 | 0.140 |
Why?
|
| United States | 5 | 2016 | 3858 | 0.130 |
Why?
|
| Pilot Projects | 2 | 2011 | 210 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 410 | 0.120 |
Why?
|
| Social Support | 1 | 2018 | 195 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 374 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2018 | 235 | 0.110 |
Why?
|
| Citrus | 1 | 2014 | 3 | 0.110 |
Why?
|
| Lycopersicon esculentum | 1 | 2014 | 4 | 0.110 |
Why?
|
| Tea | 1 | 2014 | 8 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 5 | 0.110 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 36 | 0.110 |
Why?
|
| Carbonated Beverages | 1 | 2014 | 15 | 0.110 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2014 | 14 | 0.110 |
Why?
|
| Perinatal Care | 1 | 2014 | 12 | 0.100 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 22 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2014 | 63 | 0.100 |
Why?
|
| Viral Load | 1 | 2014 | 141 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 13 | 0.100 |
Why?
|
| Risk | 1 | 2014 | 453 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2008 | 569 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2014 | 315 | 0.090 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 571 | 0.090 |
Why?
|
| Esophagoscopy | 2 | 2009 | 18 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 635 | 0.090 |
Why?
|
| Iron | 2 | 2008 | 14 | 0.090 |
Why?
|
| Confounding Factors (Epidemiology) | 2 | 2008 | 77 | 0.090 |
Why?
|
| Confidence Intervals | 2 | 2008 | 207 | 0.090 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 12 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 346 | 0.080 |
Why?
|
| Ethnic Groups | 2 | 2011 | 418 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 913 | 0.080 |
Why?
|
| Histamine H2 Antagonists | 1 | 2010 | 13 | 0.080 |
Why?
|
| Proton Pump Inhibitors | 1 | 2010 | 24 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 677 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2010 | 72 | 0.070 |
Why?
|
| Disease Progression | 1 | 2010 | 252 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 1887 | 0.070 |
Why?
|
| Trans Fatty Acids | 1 | 2009 | 4 | 0.070 |
Why?
|
| Cooking | 1 | 2009 | 17 | 0.070 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2009 | 18 | 0.070 |
Why?
|
| Ferritins | 1 | 2008 | 7 | 0.070 |
Why?
|
| Geography | 1 | 2008 | 39 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2007 | 1047 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 16 | 0.070 |
Why?
|
| beta Carotene | 1 | 2008 | 17 | 0.070 |
Why?
|
| Vitamin E | 1 | 2008 | 20 | 0.070 |
Why?
|
| Hemochromatosis | 1 | 2008 | 6 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2008 | 6 | 0.070 |
Why?
|
| Animals | 1 | 2009 | 237 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2008 | 29 | 0.070 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 21 | 0.070 |
Why?
|
| Mutation | 1 | 2008 | 86 | 0.070 |
Why?
|
| Interviews as Topic | 1 | 2008 | 305 | 0.070 |
Why?
|
| Abdominal Fat | 1 | 2007 | 10 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2008 | 294 | 0.060 |
Why?
|
| Central America | 1 | 2005 | 2 | 0.060 |
Why?
|
| Mexico | 1 | 2005 | 16 | 0.060 |
Why?
|
| Condoms | 1 | 2005 | 32 | 0.060 |
Why?
|
| Intracranial Hemorrhages | 1 | 2005 | 16 | 0.060 |
Why?
|
| Health Surveys | 1 | 2005 | 226 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2005 | 112 | 0.050 |
Why?
|
| Asian Americans | 1 | 2005 | 146 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2025 | 123 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 291 | 0.050 |
Why?
|
| Personality | 1 | 2003 | 6 | 0.050 |
Why?
|
| Health Behavior | 1 | 2005 | 332 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 352 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 235 | 0.050 |
Why?
|
| Stroke | 1 | 2005 | 297 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2005 | 305 | 0.040 |
Why?
|
| Asian Continental Ancestry Group | 2 | 2016 | 69 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 489 | 0.040 |
Why?
|
| African Continental Ancestry Group | 2 | 2016 | 117 | 0.040 |
Why?
|
| Health Status | 1 | 2003 | 256 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2020 | 5 | 0.040 |
Why?
|
| New York | 1 | 2020 | 17 | 0.040 |
Why?
|
| Child Abuse | 1 | 2020 | 44 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 43 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 46 | 0.030 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 42 | 0.030 |
Why?
|
| Bias | 2 | 2008 | 90 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 79 | 0.030 |
Why?
|
| Focus Groups | 1 | 2018 | 140 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 103 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 56 | 0.030 |
Why?
|
| Disease Management | 1 | 2018 | 106 | 0.030 |
Why?
|
| Abdomen | 2 | 2008 | 19 | 0.030 |
Why?
|
| Parents | 1 | 2020 | 298 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 130 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 516 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 187 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 290 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 1058 | 0.030 |
Why?
|
| Exercise | 1 | 2016 | 513 | 0.020 |
Why?
|
| Gastric Acid | 1 | 2010 | 4 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 110 | 0.020 |
Why?
|
| Systematized Nomenclature of Medicine | 1 | 2009 | 5 | 0.020 |
Why?
|
| Metaplasia | 1 | 2009 | 7 | 0.020 |
Why?
|
| Observer Variation | 1 | 2009 | 34 | 0.020 |
Why?
|
| Esophagus | 1 | 2009 | 12 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 31 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 30 | 0.020 |
Why?
|
| Iron, Dietary | 1 | 2008 | 7 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 74 | 0.020 |
Why?
|
| Hemochromatosis Protein | 1 | 2008 | 5 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 8 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2009 | 84 | 0.020 |
Why?
|
| Heterozygote | 1 | 2008 | 24 | 0.020 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2008 | 8 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 6 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 11 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 32 | 0.020 |
Why?
|
| Thigh | 1 | 2007 | 10 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2007 | 17 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2007 | 28 | 0.020 |
Why?
|
| Anthropometry | 1 | 2006 | 54 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 319 | 0.020 |
Why?
|
| Prevalence | 1 | 2008 | 785 | 0.010 |
Why?
|
| Age Distribution | 1 | 2006 | 221 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 989 | 0.010 |
Why?
|
| African Americans | 1 | 2005 | 394 | 0.010 |
Why?
|
Concepts
(219)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->